Spruce Biosciences Net Loss History

SPRB Stock  USD 58.40  -0.65  -1.10%   
Net Loss for Spruce Biosciences Common is shaped by operating scale, margin structure, and capital allocation choices. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. Spruce Biosciences last reported Net Loss of -43.6 M, from -41.6 M in the year before. Spruce Biosciences' Net Loss is on a recovering trend. View All Fundamentals
 
Net Loss  
 First Reported
2010-12-31
 Previous Quarter
-41.6 M
 Current Value
-43.6 M
 Quarterly Volatility
16.7 M
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Latest Spruce Biosciences' Net Loss Growth Pattern

Net Loss for Spruce Biosciences moved from -41.6 M to -43.6 M over the most recent period. The most recent value of -43.6 M sits within a slightly volatile historical range. The slope of Spruce Biosciences' Net Loss trend captures whether the metric has generally strengthened or weakened.
Net Loss10 Years Trend
Slightly volatile
All figures are presented for informational review.
   Net Income Applicable To Common Shares   
       Timeline  

Net Loss Trend Statistics

Arithmetic Mean-23,375,476
Coefficient Of Variation-71.33
Mean Deviation 15,522,913
Median-9,858,000
Standard Deviation 16,672,768
Sample Variance278T
Range36.3M
R-Value-0.87
Mean Square Error70.2T
R-Squared 0.76
Slope-2,884,580
Total Sum of Squares4447.7T

Spruce Biosciences Net Loss History

2026-43.6 M
2025-41.6 M
2022-46.2 M
2021-42.3 M
2020-29.5 M
2019-13.1 M

Methodology, Assumptions & Data Sources

Below you can see Spruce Biosciences's Net Loss across recent years. Some metrics drift back toward their average over time.

Macroaxis compiles Spruce Biosciences Common metrics from periodic company reporting and market reference feeds and applies consistent transformation rules before display. Not all fields update in real time. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board
Last reviewed on March 6th, 2026